vs
e.l.f. Beauty, Inc.（ELF）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是e.l.f. Beauty, Inc.的1.0倍（$493.8M vs $489.5M），e.l.f. Beauty, Inc.净利率更高（8.0% vs 6.8%，领先1.2%），e.l.f. Beauty, Inc.同比增速更快（37.8% vs -1.7%）
e.l.f. Beauty是美国知名彩妆品牌，2004年创立，总部位于加利福尼亚州奥克兰。品牌产品线丰富，涵盖沐浴护肤产品、矿物彩妆、专业美妆工具、眼线笔、口红、腮红、睫毛膏等多个品类，产品销往全球18个国家，入驻Target、沃尔玛等主流零售渠道，过半营收来自品牌官网。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
ELF vs MD — 直观对比
营收规模更大
MD
是对方的1.0倍
$489.5M
营收增速更快
ELF
高出39.5%
-1.7%
净利率更高
ELF
高出1.2%
6.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $489.5M | $493.8M |
| 净利润 | $39.4M | $33.7M |
| 毛利率 | 71.0% | — |
| 营业利润率 | 13.8% | 9.9% |
| 净利率 | 8.0% | 6.8% |
| 营收同比 | 37.8% | -1.7% |
| 净利润同比 | 128.1% | 10.5% |
| 每股收益（稀释后） | $0.65 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELFMD
| Q4 25 | $489.5M | $493.8M | ||
| Q3 25 | $343.9M | $492.9M | ||
| Q2 25 | $353.7M | $468.8M | ||
| Q1 25 | — | $458.4M | ||
| Q4 24 | — | $502.4M | ||
| Q3 24 | — | $511.2M | ||
| Q2 24 | — | $504.3M | ||
| Q1 24 | — | $495.1M |
净利润ELFMD
| Q4 25 | $39.4M | $33.7M | ||
| Q3 25 | $3.0M | $71.7M | ||
| Q2 25 | $33.3M | $39.3M | ||
| Q1 25 | — | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | — | $19.4M | ||
| Q2 24 | — | $-153.0M | ||
| Q1 24 | — | $4.0M |
毛利率ELFMD
| Q4 25 | 71.0% | — | ||
| Q3 25 | 69.4% | — | ||
| Q2 25 | 69.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ELFMD
| Q4 25 | 13.8% | 9.9% | ||
| Q3 25 | 2.2% | 13.8% | ||
| Q2 25 | 13.8% | 12.8% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | -31.3% | ||
| Q1 24 | — | 3.2% |
净利率ELFMD
| Q4 25 | 8.0% | 6.8% | ||
| Q3 25 | 0.9% | 14.5% | ||
| Q2 25 | 9.4% | 8.4% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | -30.3% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）ELFMD
| Q4 25 | $0.65 | $0.40 | ||
| Q3 25 | $0.05 | $0.84 | ||
| Q2 25 | $0.58 | $0.46 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.23 | ||
| Q2 24 | — | $-1.84 | ||
| Q1 24 | — | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.8M | $375.2M |
| 总债务越低越好 | $816.7M | $570.5M |
| 股东权益账面价值 | $1.2B | $865.9M |
| 总资产 | $2.3B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.70× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资ELFMD
| Q4 25 | $196.8M | $375.2M | ||
| Q3 25 | $194.4M | $340.1M | ||
| Q2 25 | $170.0M | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
总债务ELFMD
| Q4 25 | $816.7M | $570.5M | ||
| Q3 25 | $831.6M | $577.2M | ||
| Q2 25 | $256.7M | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ELFMD
| Q4 25 | $1.2B | $865.9M | ||
| Q3 25 | $1.1B | $890.7M | ||
| Q2 25 | $804.9M | $833.8M | ||
| Q1 25 | — | $789.2M | ||
| Q4 24 | — | $764.9M | ||
| Q3 24 | — | $732.5M | ||
| Q2 24 | — | $706.5M | ||
| Q1 24 | — | $856.2M |
总资产ELFMD
| Q4 25 | $2.3B | $2.2B | ||
| Q3 25 | $2.3B | $2.2B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.2B |
负债/权益比ELFMD
| Q4 25 | 0.70× | 0.66× | ||
| Q3 25 | 0.73× | 0.65× | ||
| Q2 25 | 0.32× | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.4M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $52.8M | — |
| 自由现金流率自由现金流/营收 | 10.8% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 1.51× | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ELFMD
| Q4 25 | $59.4M | $114.1M | ||
| Q3 25 | $23.4M | $137.3M | ||
| Q2 25 | $27.2M | $137.2M | ||
| Q1 25 | — | $-117.5M | ||
| Q4 24 | — | $133.0M | ||
| Q3 24 | — | $91.8M | ||
| Q2 24 | — | $107.0M | ||
| Q1 24 | — | $-125.2M |
自由现金流ELFMD
| Q4 25 | $52.8M | — | ||
| Q3 25 | $16.6M | — | ||
| Q2 25 | $20.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ELFMD
| Q4 25 | 10.8% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ELFMD
| Q4 25 | 1.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ELFMD
| Q4 25 | 1.51× | 3.39× | ||
| Q3 25 | 7.82× | 1.91× | ||
| Q2 25 | 0.82× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELF
暂无分部数据
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
